Literature DB >> 1540893

Clinical applications of flow cytometry. Immunologic methods for measuring cell membrane and cytoplasmic antigens.

C C Stewart1.   

Abstract

Flow cytometric analysis is the method of choice for classifying leukemia and lymphomas. When combined with other clinical and morphometric data, a definitive diagnosis can be made in the most difficult cases. By using a combination of specific antibodies that are each labeled with a different fluorochrome, panels can be designed to follow residual disease with greater precision than any other method. The detection of intracellular proteins is less well developed. Because antibodies can bind nonspecifically to dead cell components, there may be considerable biological noise. This noise reduces the sensitivity for detecting the desired protein within the cell. Until this problem is solved, it is likely that other methods may provide more reliable data. The major advantages of flow cytometry are rapid cell processing, cell by cell analysis, and the simultaneous evaluation of multiple markers. The latter is especially important because more tests can be performed using less clinical material. When flow cytometric results are combined with histologic results, the confidence in professional interpretation is far greater than either can provide alone. It is likely that the future application of these approaches will significantly improve diagnosis and patient care.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540893     DOI: 10.1002/1097-0142(19920315)69:6+<1543::aid-cncr2820691307>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  B7-1 gene transfer into human cancer cells by infection with an adenovirus-B7 (Ad-B7) expression vector.

Authors:  S Dessureault; F Graham; S Gallinger
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

2.  The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.

Authors:  Ana Paula Alegretti; Christina Matzenbacher Bittar; Rosane Bittencourt; Amanda Kirchner Piccoli; Laiana Schneider; Lúcia Mariano Silla; Suzane Dal Bó; Ricardo Machado Xavier
Journal:  Rev Bras Hematol Hemoter       Date:  2011

3.  T-cell large granular lymphocytic leukemia: treatment experience with fludarabine.

Authors:  Renata Oliveira Costa; Marcelo Bellesso; Dalton Alencar Fischer Chamone; Milton Artur Ruiz; Abrahão Elias Hallack Neto; Vera Lucia Aldred; Juliana Pereira
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.